Analysts think ATOS stock price could increase by 561%
Jul 07, 2025, 11:25 AM
-4.84%
What does ATOS do
Atossa Therapeutics, based in Seattle, focuses on developing oral (Z)-endoxifen for breast cancer treatment and prevention, having completed four Phase I and two Phase II clinical studies. The company went public on November 8, 2012, and employs 10 people.
6 analysts think ATOS stock price will increase by 560.70%. The current median analyst target is $5.61 compared to a current stock price of $0.85. The lowest analysts target is $4.04 and the highest analyst target is $7.61.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.